Dr. Ranjith Ramasamy discusses research evaluating COVID-19 and erectile dysfunction

Data showed that 87.8% of treated patients and 96.1% of patients who completed the study achieved normal 24-hour mean plasma testosterone values (222 to 800 ng/dL) at 90-day follow-up.

“I think it's really important to understand the role of prevention and early detection,” says Michael Lutz, MD.

Overall, more than 78% of consumers were able to appropriately self-select to use avanafil using the drug facts label (DFL) and the assistive app, compared with 56% of consumers using the DFL alone.

“I think that the audience should know that there is a movement going on,” says Geo Espinosa, ND.

The study is set to begin in January 2024.

Novel research to evaluate noninvasive treatments in erectile dysfunction and chronic pelvic pain